We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$4.02B
AUM Growth
+$1.44B
Cap. Flow
+$1.15B
Cap. Flow %
28.6%
Top 10 Hldgs %
94.04%
Holding
32
New
3
Increased
1
Reduced
3
Closed
6

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$1.03B
2
PL icon
Planet Labs
PL
+$84.5M
3
PAYP
PayPay
PAYP
+$66.1M
4
LIFE
Ethos Technologies Inc
LIFE
+$44.6M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$68.8M
2
RVMD icon
Revolution Medicines
RVMD
+$5.31M
3
WGS icon
GeneDx Holdings
WGS
+$2.95M
4
EXAS
Exact Sciences
EXAS
+$2.36M
5
GLUE icon
Monte Rosa Therapeutics
GLUE
+$1.16M

Sector Composition

Rank Sector Weight
1 Technology 34.27%
2 Financials 26.67%
3 Industrials 24.53%
4 Healthcare 14.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNYA icon
26
Tenaya Therapeutics
TNYA
$168M
$632K 0.02%
915,705
– –
DXCM icon
27
DexCom
DXCM
$27.6B
– –
-1,036,937
Closed -$68.8M
EXAS
28
DELISTED
Exact Sciences
EXAS
– –
-23,205
Closed -$2.36M
FULC icon
29
Fulcrum Therapeutics
FULC
$248M
– –
-14,262
Closed -$161K
QNCX icon
30
Quince Therapeutics
QNCX
$17.5M
– –
-946
Closed -$634K
RGEN icon
31
Repligen
RGEN
$7.44B
– –
-383
Closed -$62.8K
WGS icon
32
GeneDx Holdings
WGS
$1.75B
– –
-22,711
Closed -$2.95M
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q1 2026 Portfolio in Review

As of Q1 2026, Alphabet Inc held 32 positions worth $4.02B, up 56% from $2.58B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Alphabet Inc deployed $1.15B of net new capital in Q1 2026, opening 3 new positions and adding to 1 existing holding. Its largest new stake was CME Group: 3,484,020 shares worth $1.03B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 50% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Revolution Medicines, an estimated $5.31M trimmed.

  • Alphabet Inc's largest Q1 2026 buy was CME Group: 3,484,020 shares worth $1.03B.
  • Alphabet Inc added most to Planet Labs in Q1 2026, an estimated $84.5M increase.
  • Alphabet Inc's biggest Q1 2026 reduction was Revolution Medicines, cutting an estimated $5.31M.
  • Alphabet Inc fully exited DexCom in Q1 2026, selling an estimated $68.8M.
  • Alphabet Inc's ten largest holdings make up 94% of its $4.02B portfolio in Q1 2026.
  • Alphabet Inc opened 3 new positions and closed 6 in Q1 2026.
  • Alphabet Inc's portfolio value rose 56% quarter-over-quarter to $4.02B.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.